Individualized Medication Guidance for Cancer (118 Genes)
Product Quick Detail
- Minimum Order
- 1
- Packaging
- N/A
- Delivery
- 15 Days
Specifications
- Country: China (Mainland)
- Business Type:
- Market:
- Founded Year:
- Address:Building C, Block 88 Kechuang 6th Street, Yizhuang Biomedical Park, Beijing
- Contact:capitalbio technology
Other products from CapitalBio Technology Co., Ltd.
Relate products of Individualized Medication Guidance for Cancer (118 Genes)
This test detects 346 genes, including HRR pathway genes. The content involves targeted therapy, immunotherapy, chemotherapy and hereditary risk assessment, and provides comprehensive medication reference for prostate cancer patients. Features of Individualized Medication ...
Gynecologic Cancer Surgery According to the latest Chinese women\'s new cancer statistics, cervical cancer and ovarian cancer are in the top ten new cases of female cancer (about 110,000 and 60,000 respectively). With the widespread clinical use of poly(ADP-ribose) polymerase ...
This test detects 84 genes related to gastrointestinal cancer, provides information on targeted drug, chemotherapy, and hereditary risk assessment. Features of Individualized Medication Guidance for Gastrointestinal Cancer Treatment Targeted drug Gastrointestinal targeted drug ...
This test detects 800 genes related to targeted therapy, chemotherapy and endocrine drug, hereditary tumor, immunotherapy-related information (MSI and TMB), tumor core signaling pathway and tumor prognosis. The types of variants detected include SNV, InDel, amplifications and ...
